Tomorrow Investor

DRAGANFLY TO ACQUIRE SKIP DYNAMIX FIXED WING ULTRA-LOW COST, MASS PRODUCIBLE TECHNOLOGY, INTELLECTUAL PROPERTY AND INFRASTRUCTURE

Draganfly Acquires Skip Dynamix for Advanced UAV Technology | GlobeNewsWire

Integrates Ultra-Low Cost, Mass-Producible Long-Range Surveillance and One Way Systems into the Draganfly Platform of Drones Tampa, FL., May 18, 2026 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, is pleased to announce that it has entered into a definitive asset purchase agreement (the “Agreement”) with Skip Dynamix, Corporation (“Skip Dynamix”), a developer of ultra-low-cost, mass-producible fixed-wing unmanned aerial systems designed for long-range intelligence, surveillance and reconnaissance (“ISR”), electronic warfare support, logistics, and one-way missions.

This excerpt is quoted from the original release. Read the full announcement on GlobeNewsWire.

Brief Summary

Draganfly has taken a significant step in enhancing its UAV capabilities by acquiring Skip Dynamix, a pioneer in cost-effective fixed-wing drone technology. This acquisition aligns with Draganfly’s commitment to delivering innovative solutions.

  • Expands surveillance and reconnaissance capabilities.
  • Enhances logistics and electronic warfare support.
  • Positions Draganfly competitively in the drone market.

Why it matters: The integration of Skip Dynamix’s technology is poised to significantly enhance Draganfly’s position in the UAV industry, driving growth and efficiency.

Read the Full Article

This is a summary of the press release. For the complete article and any additional details, please visit the original source.

Read Full Article

Attribution: Original press release by GlobeNewsWire on . We provide an AI-generated summary and links for convenience. Always verify details with the original source. Not investment advice. For informational purposes only.

Tomorrow Investor
The Tomorrow Investor

Markets research for retail investors

Independent coverage of small-cap equities, biotech catalysts, and emerging market opportunities.